Found 1 articles for: "Atopic Dermatitis Among Adolescent"

A Qualitative Study on Dupilumab's Impact on Atopic Dermatitis Among Adolescent and Adult Patients

February 2023 | Volume 22 | Issue 2 | Original Article | 148 | Copyright © February 2023

Background: Atopic dermatitis (AD) is the most common inflammatory skin disease and dupilumab is US Food and Drug Administration-approved in both adult and pediatric AD patients.
Read More